Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: From bench to point-of-care
- 8 May 2015
- journal article
- review article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 240 (6), 821-831
- https://doi.org/10.1177/1535370215584931
Abstract
Cardiac ischemia associated with acute coronary syndrome and myocardial infarction is a leading cause of mortality and morbidity in the world. A rapid detection of the ischemic events is critically important for achieving timely diagnosis, treatment and improving the patient's survival and functional recovery. This minireview provides an overview on the current biomarker research for detection of acute cardiac ischemia. We primarily focus on inosine and hypoxanthine, two by-products of ATP catabolism. Based on our published findings of elevated plasma concentrations of inosine/hypoxanthine in animal laboratory and clinical settings, since 2006 we have originally proposed that these two purine molecules can be used as rapid and sensitive biomarkers for acute cardiac ischemia at its very early onset (within 15 min), hours prior to the release of heart tissue necrosis biomarkers such as cardiac troponins. We further developed a chemiluminescence technology, one of the most affordable and sensitive analytical techniques, and we were able to reproducibly quantify and differentiate total hypoxanthine concentrations in the plasma samples from healthy individuals versus patients suffering from ischemic heart disease. Additional rigorous clinical studies are needed to validate the plasma inosine/hypoxanthine concentrations, in conjunction with other current cardiac biomarkers, for a better revelation of their diagnostic potentials for early detection of acute cardiac ischemia.Keywords
This publication has 40 references indexed in Scilit:
- A rapid and simple chemiluminescence method for screening levels of inosine and hypoxanthine in non‐traumatic chest pain patientsLuminescence, 2011
- Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injuryJCI Insight, 2008
- Loss of Myocardial Ischemic Postconditioning in Adenosine A 1 and Bradykinin B 2 Receptors Gene Knockout MiceCirculation, 2008
- An HPLC method for determination of inosine and hypoxanthine in human plasma from healthy volunteers and patients presenting with potential acute cardiac ischemiaJournal of Chromatography B, 2007
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary SyndromesClinical Chemistry, 2007
- Effects of salicylic acid on post-ischaemic ventricular function and purine efflux in isolated mouse heartsBiomarkers, 2007
- Unbound Free Fatty Acids and Heart-Type Fatty Acid–Binding Protein: Diagnostic Assays and Clinical ApplicationsClinical Chemistry, 2006
- Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary SyndromeClinical Chemistry, 2005
- Coronary artery disease in the developing worldAmerican Heart Journal, 2004
- A Comparative Study of the Concentrations of Hypoxanthine, Xanthine, Uric Acid and Allantoin in the Peripheral Blood of Normals and Patients with Acute Myocardial Infarction and Other Ischaemic Diseasescclm, 1994